Exchange: NASDAQ·Updated 07:30 PM EST

ALMR Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 03

Estimated EPS

-$0.20

Reported EPS

-$0.19

Surprise

+5.71%

Estimated Rev

$30.22M

Reported Rev

$33.54M

Surprise

+11.01%

• Reported GAAP EPS of -$0.19 up 72.46% YoY • Reported revenue of $33.55M up 68.51% YoY • Alamar Biosciences raised full-year 2026 revenue guidance to $121M to $123M, representing growth of 64% at the midpoint versus full-year 2025, from previous expectations of $116M to $120M.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.26
--
--
N/A
Q3 '26
-$0.20
-$0.19
5.71%
BEAT
Q2 '26
-$0.31
-$0.22
28.54%
BEAT
Q1 '26
-$1.71
--
--
N/A

Advertisement|Remove ads.